News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Pucci Paolo
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Pucci Paolo (Director) has filed a Form 4 on Merus N.V.|
Txns:
| Granted 14,414 options to buy
@ $23.29, valued at
$335.7k
|
|
| 04/27/2023 |
4
| Pucci Paolo (Director) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Granted 616 shares
@ $0 |
|
| 04/04/2023 |
4
| Pucci Paolo (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 25,200 options to buy
@ $17.66, valued at
$445k
|
|
| 06/02/2022 |
4
| Pucci Paolo (Director) has filed a Form 4 on Merus N.V.|
Txns:
| Granted 16,604 options to buy
@ $18.56, valued at
$308.2k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Pucci Paolo (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 16,500 options to buy
@ $18.26, valued at
$301.3k
|
|
| 11/19/2021 |
4
| Pucci Paolo (Director) has filed a Form 4 on Trillium Therapeutics Inc.|
Txns:
| Disposed/sold 67,000 options to buy
@ $15.5, valued at
$1M
|
|
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2020 |
4
| Pucci Paolo (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 33,000 options to buy
@ $9.78, valued at
$322.7k
|
|
| 04/02/2020 |
3
| Pucci Paolo (Director) has filed a Form 3 on Replimune Group, Inc. |
| 01/16/2020 |
4
| Pucci Paolo (CEO) has filed a Form 4 on ARQULE INC|
Txns:
| Unknown transaction of 1,235,782 shares
@ $20, valued at
$24.7M
Disposed/sold 242,502 options to buy
@ $1.16, valued at
$281.3k
Disposed/sold 120,000 options to buy
@ $1.79, valued at
$214.8k
Disposed/sold 300,000 options to buy
@ $1.53, valued at
$459k
Disposed/sold 600,000 options to buy
@ $0.95, valued at
$570k
Disposed/sold 249,000 options to buy
@ $1.75, valued at
$435.8k
Disposed/sold 80,000 options to buy
@ $2.48, valued at
$198.4k
Disposed/sold 150,000 options to buy
@ $5.48, valued at
$822k
Disposed/sold 650,850 options to buy
@ $3.68, valued at
$2.4M
Disposed/sold 100,000 options to buy
@ $4.14, valued at
$414k
Disposed/sold 14,925 options to buy
@ $6.7, valued at
$100k
|
|
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2019 |
4
| Pucci Paolo (Director) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Granted 1,565 shares
@ $0 |
|
| 03/18/2019 |
4
| Pucci Paolo (CEO) has filed a Form 4 on ARQULE INC|
Txns:
| Exercised 50,000 options to buy
@ $1.16, valued at
$58k
|
|
| 03/14/2019 |
4
| Pucci Paolo (CEO) has filed a Form 4 on ARQULE INC|
Txns:
| Granted 300,000 options to buy
@ $0.95, valued at
$285k
|
|
| 01/17/2019 |
4
| Pucci Paolo (CEO) has filed a Form 4 on ARQULE INC|
Txns:
| Granted 650,850 options to buy
@ $3.68, valued at
$2.4M
|
|
| 07/25/2018 |
4
| Pucci Paolo (CEO) has filed a Form 4 on ARQULE INC|
Txns:
| Granted 150,000 options to buy
@ $5.48, valued at
$822k
|
|
| 06/11/2018 |
4
| Pucci Paolo (CEO) has filed a Form 4 on ARQULE INC|
Txns:
| Paid exercise price by delivering 352,286 shares
@ $5.78, valued at
$2M
Exercised 101,264 options to buy
@ $3.95, valued at
$400k
Exercised 398,736 options to buy
@ $3.95, valued at
$1.6M
|
|
| 05/25/2018 |
4
| Pucci Paolo (Director) has filed a Form 4 on NEWLINK GENETICS CORP|
Txns:
| Granted 27,777 options to buy
@ $5.33, valued at
$148.1k
|
|
| 05/18/2018 |
4
| Pucci Paolo (CEO) has filed a Form 4 on ARQULE INC|
Txns:
| Bought 15,000 shares
@ $3.3899, valued at
$50.8k
|
|
| 05/11/2018 |
4
| Pucci Paolo (CEO) has filed a Form 4 on ARQULE INC|
Txns:
| Granted 80,000 options to buy
@ $2.48, valued at
$198.4k
|
|
| 05/11/2018 |
4
| Pucci Paolo (CEO) has filed a Form 4 on ARQULE INC|
Txns:
| Bought 1,300 shares
@ $2.6362, valued at
$3.4k
|
|
| 05/10/2018 |
4
| Pucci Paolo (CEO) has filed a Form 4 on ARQULE INC|
Txns:
| Granted 249,000 options to buy
@ $1.75, valued at
$435.8k
|
|
| 05/03/2018 |
4
| Pucci Paolo (Director) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Granted 1,824 shares
@ $0 |
|
| 09/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|